Calcineurin Inhibitors: all 995 studies that test it
Page 9 of 10. Open to participants first (83), then studies with results posted, then the rest; newest registration first within each.
- Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft RecipientsCompletedNCT00518271Phase 2
- Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCTCompletedNCT00516152Phase 2
- Medical Treatment of Colitis in Patients With Hermansky-Pudlak SyndromeWithdrawnNCT00514982Phase 2
- A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft FailureCompletedNCT00510913Phase 4
- Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-oldCompletedNCT00510003Phase 4
- Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical SettingCompletedNCT00509990Phase 4
- Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic DiseaseCompletedNCT00507832Phase 2
- Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving SirolimusCompletedNCT00507793Phase 4
- Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant RecipientsCompletedNCT00504543Phase 2
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)CompletedNCT00502073Phase 3
- Cord Blood Expansion on Mesenchymal Stem CellsCompletedNCT00498316Phase 1
- Fibrosis in Renal AllograftsStatus unknownNCT00493194Phase 4
- A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on TacrolimusCompletedNCT00492661Phase 4
- Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic SyndromeCompletedNCT00488436Phase 4
- A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic DermatitisCompletedNCT00484003Phase 4
- A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney TransplantationCompletedNCT00481819Phase 3
- Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant SubjectsCompletedNCT00481481Phase 3
- Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus OintmentCompletedNCT00480896Phase 3
- Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus OintmentCompletedNCT00480610Phase 3
- Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + SteroidCompletedNCT00469131Phase 3
- Strategies to Improve Islet SurvivalCompletedNCT00464555Phase 2
- Topical FK506 (Tacrolimus) for Prevention of Immune Reactions Following Penetrating KeratoplastyTerminatedNCT00463723Phase 2/3
- Maintenance Neoral Monotherapy Compared to Bitherapy in Renal TransplantationCompletedNCT00461825Phase 3
- A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver TransplantationCompletedNCT00459719Phase 3
- Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine InhibitorsCompletedNCT00456235Phase 4
- Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot StudyStatus unknownNCT00443105Phase 2
- Islet Transplantation in Type 1 DiabetesCompletedNCT00434811Phase 3
- Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative StudyCompletedNCT00429377Phase 3
- Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant RecipientsCompletedNCT00428064Phase 3
- Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004CompletedNCT00426101Phase 3
- Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis PatientsCompletedNCT00408187Phase 3
- Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With RestasisCompletedNCT00407043Phase 4
- Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?CompletedNCT00405431Not applicable
- Clobetasol Versus Pimecrolimus for Vulvar Lichen SclerosusCompletedNCT00393263Phase 2
- Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to FluorouracilCompletedNCT00389870Phase 3
- A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver RecipientsCompletedNCT00384202Phase 3
- A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney RecipientsCompletedNCT00384137Phase 3
- Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to PterygiaCompletedNCT00383396Phase 4
- The Effectiveness of Lower Cyclosporine Doses for PsoriasisWithdrawnNCT00377325Phase 2
- Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesTerminatedNCT00376519Phase 1
- Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver TransplantationTerminatedNCT00375895Phase 3
- Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus NephritisCompletedNCT00371319Phase 4
- Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic DermatitisCompletedNCT00367393Phase 4
- Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic DermatitisCompletedNCT00351052Phase 3
- Efficacy of Topical Cyclosporin for Ocular RosaceaCompletedNCT00348335Phase 4
- Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis PatientsCompletedNCT00347048Phase 3
- Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid CancerCompletedNCT00346359Phase 2
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic MalignanciesCompletedNCT00343798Phase 1
- Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.CompletedNCT00337493Phase 4
- Pharmacokinetic Study on the Combination of Everolimus-TacrolimusStatus unknownNCT00325325Phase 2
- Treatment of Oral Erosive Lichen Planus With Pimecrolimus CreamTerminatedNCT00321750Phase 2
- Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal GraftsCompletedNCT00321074Phase 3
- A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA PatientsCompletedNCT00319917Phase 4
- Sirolimus and Cyclosporine for Treatment-Resistant Aplastic AnemiaStatus unknownNCT00319878Phase 1/2
- Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)CompletedNCT00317681Phase 2
- Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple MyelomaCompletedNCT00313625Phase 2
- An Open Study for Steroid Resistant, Non-Thymectomized MG PatientsCompletedNCT00309101Phase 3
- FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) PatientsCompletedNCT00309088Phase 3
- Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family DonorStatus unknownNCT00304720Phase 2
- Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerCompletedNCT00304018Phase 1
- To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LNCompletedNCT00302549Not applicable
- Tacrolimus Treatment of Patients With Idiopathic Focal Segmental GlomerulosclerosisWithdrawnNCT00302536Not applicable
- Tacrolimus Treatment of Patients With Idiopathic Membranous NephropathyCompletedNCT00302523Not applicable
- Combination Therapy of Betaseron-Prograf in Multiple SclerosisStatus unknownNCT00298662Phase 2
- Optimizing Prograf® Therapy in Renal Transplant PatientsCompletedNCT00297765Phase 4
- Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney TransplantationCompletedNCT00297310Phase 4
- To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.CompletedNCT00296361Phase 3
- Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.CompletedNCT00296309Phase 3
- Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerCompletedNCT00296023Not applicable
- Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.CompletedNCT00295594Phase 3
- A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293930Phase 3
- A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293917Phase 3
- A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293891Phase 3
- Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic CancerCompletedNCT00290641Not applicable
- Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA)Status unknownNCT00290069Phase 4
- Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet TransplantationCompletedNCT00286624Phase 1/2
- The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant RecipientsCompletedNCT00275535Phase 4
- Aerosol Cyclosporine for Prevention of Lung RejectionCompletedNCT00268515Phase 2
- Metabolic Pattern of Cyclosporine A and Acute Renal FailureCompletedNCT00264355Phase 4
- Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft RecipientsCompletedNCT00261820Phase 4
- Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney TransplantsCompletedNCT00257387Phase 1/2
- Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic CancerCompletedNCT00255710Phase 1
- Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant RecipientsStatus unknownNCT00252655Phase 4
- Evaluation of Topical Antipsoriatics in the Psoriasis Plaque TestCompletedNCT00236171Not applicable
- Pimecrolimus Cream 1% in Adult Patients With Perioral DermatitisCompletedNCT00232115Phase 3
- Verification Study of Ciclosporin for Atopic DermatitisCompletedNCT00232076Phase 3
- Long-term Study of Ciclosporin for Atopic DermatitisCompletedNCT00232063Phase 3
- Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic DermatitisCompletedNCT00232011Phase 3
- Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic DermatitisCompletedNCT00231998Phase 3
- Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand DermatitisCompletedNCT00226707Phase 3
- Cutaneous Lupus Erythematosus and ElidelWithdrawnNCT00222183Not applicable
- Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant PatientsCompletedNCT00213590Phase 3
- Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney TransplantationStatus unknownNCT00204191Phase 4
- Comparison of Immunosuppression Protocols After LTx in ChildrenCompletedNCT00195988Phase 4
- Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking SirolimusCompletedNCT00195468Phase 4
- A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney TransplantationCompletedNCT00189839Phase 3
- A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.CompletedNCT00189826Phase 3
- Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent AsthmaCompletedNCT00189787Phase 2
- A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT RecipientsCompletedNCT00189761Phase 2
- A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-CompletedNCT00189748Phase 2